Global Multiplexed Diagnostics Market Research Report 2023

Report ID: 1983814 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Multiplexed Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Very High Density Multiplexed Assays (Above 10,000-plex)
        1.2.3 High Density Multiplexed Assays (500 Below plex Below 10,000)
        1.2.4 Medium Density Multiplexed Assays (plex Below 500)
        1.2.5 Low Density Multiplexed Assays (plex Below 5)
        1.2.6 Next Generation Sequencing Assays
    1.3 Market by Application
        1.3.1 Global Multiplexed Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Academic Research Institutes
        1.3.3 Hospital
        1.3.4 Pharmaceutical Companies
        1.3.5 Clinical Research Organizations
        1.3.6 Diagnostic Laboratories
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Multiplexed Diagnostics Market Perspective (2017-2028)
    2.2 Multiplexed Diagnostics Growth Trends by Region
        2.2.1 Multiplexed Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Multiplexed Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Multiplexed Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Multiplexed Diagnostics Market Dynamics
        2.3.1 Multiplexed Diagnostics Industry Trends
        2.3.2 Multiplexed Diagnostics Market Drivers
        2.3.3 Multiplexed Diagnostics Market Challenges
        2.3.4 Multiplexed Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Multiplexed Diagnostics Players by Revenue
        3.1.1 Global Top Multiplexed Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Multiplexed Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Multiplexed Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Multiplexed Diagnostics Revenue
    3.4 Global Multiplexed Diagnostics Market Concentration Ratio
        3.4.1 Global Multiplexed Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Multiplexed Diagnostics Revenue in 2021
    3.5 Multiplexed Diagnostics Key Players Head office and Area Served
    3.6 Key Players Multiplexed Diagnostics Product Solution and Service
    3.7 Date of Enter into Multiplexed Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplexed Diagnostics Breakdown Data by Type
    4.1 Global Multiplexed Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Multiplexed Diagnostics Forecasted Market Size by Type (2023-2028)
5 Multiplexed Diagnostics Breakdown Data by Application
    5.1 Global Multiplexed Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Multiplexed Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Multiplexed Diagnostics Market Size (2017-2028)
    6.2 North America Multiplexed Diagnostics Market Size by Country (2017-2022)
    6.3 North America Multiplexed Diagnostics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Multiplexed Diagnostics Market Size (2017-2028)
    7.2 Europe Multiplexed Diagnostics Market Size by Country (2017-2022)
    7.3 Europe Multiplexed Diagnostics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Multiplexed Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Multiplexed Diagnostics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Multiplexed Diagnostics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Multiplexed Diagnostics Market Size (2017-2028)
    9.2 Latin America Multiplexed Diagnostics Market Size by Country (2017-2022)
    9.3 Latin America Multiplexed Diagnostics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Multiplexed Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Multiplexed Diagnostics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Multiplexed Diagnostics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Agilent Technologies
        11.1.1 Agilent Technologies Company Detail
        11.1.2 Agilent Technologies Business Overview
        11.1.3 Agilent Technologies Multiplexed Diagnostics Introduction
        11.1.4 Agilent Technologies Revenue in Multiplexed Diagnostics Business (2017-2022)
        11.1.5 Agilent Technologies Recent Development
    11.2 Bio-Rad Laboratories
        11.2.1 Bio-Rad Laboratories Company Detail
        11.2.2 Bio-Rad Laboratories Business Overview
        11.2.3 Bio-Rad Laboratories Multiplexed Diagnostics Introduction
        11.2.4 Bio-Rad Laboratories Revenue in Multiplexed Diagnostics Business (2017-2022)
        11.2.5 Bio-Rad Laboratories Recent Development
    11.3 BioMerieux
        11.3.1 BioMerieux Company Detail
        11.3.2 BioMerieux Business Overview
        11.3.3 BioMerieux Multiplexed Diagnostics Introduction
        11.3.4 BioMerieux Revenue in Multiplexed Diagnostics Business (2017-2022)
        11.3.5 BioMerieux Recent Development
    11.4 F. Hoffmann-La Roche
        11.4.1 F. Hoffmann-La Roche Company Detail
        11.4.2 F. Hoffmann-La Roche Business Overview
        11.4.3 F. Hoffmann-La Roche Multiplexed Diagnostics Introduction
        11.4.4 F. Hoffmann-La Roche Revenue in Multiplexed Diagnostics Business (2017-2022)
        11.4.5 F. Hoffmann-La Roche Recent Development
    11.5 Illumina
        11.5.1 Illumina Company Detail
        11.5.2 Illumina Business Overview
        11.5.3 Illumina Multiplexed Diagnostics Introduction
        11.5.4 Illumina Revenue in Multiplexed Diagnostics Business (2017-2022)
        11.5.5 Illumina Recent Development
    11.6 Luminex
        11.6.1 Luminex Company Detail
        11.6.2 Luminex Business Overview
        11.6.3 Luminex Multiplexed Diagnostics Introduction
        11.6.4 Luminex Revenue in Multiplexed Diagnostics Business (2017-2022)
        11.6.5 Luminex Recent Development
    11.7 Hologic
        11.7.1 Hologic Company Detail
        11.7.2 Hologic Business Overview
        11.7.3 Hologic Multiplexed Diagnostics Introduction
        11.7.4 Hologic Revenue in Multiplexed Diagnostics Business (2017-2022)
        11.7.5 Hologic Recent Development
    11.8 Thermo Fisher Scientific
        11.8.1 Thermo Fisher Scientific Company Detail
        11.8.2 Thermo Fisher Scientific Business Overview
        11.8.3 Thermo Fisher Scientific Multiplexed Diagnostics Introduction
        11.8.4 Thermo Fisher Scientific Revenue in Multiplexed Diagnostics Business (2017-2022)
        11.8.5 Thermo Fisher Scientific Recent Development
    11.9 Siemens Healthineers
        11.9.1 Siemens Healthineers Company Detail
        11.9.2 Siemens Healthineers Business Overview
        11.9.3 Siemens Healthineers Multiplexed Diagnostics Introduction
        11.9.4 Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2017-2022)
        11.9.5 Siemens Healthineers Recent Development
    11.10 Abbott Laboratories
        11.10.1 Abbott Laboratories Company Detail
        11.10.2 Abbott Laboratories Business Overview
        11.10.3 Abbott Laboratories Multiplexed Diagnostics Introduction
        11.10.4 Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2017-2022)
        11.10.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Multiplexed Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Very High Density Multiplexed Assays (Above 10,000-plex)
    Table 3. Key Players of High Density Multiplexed Assays (500 Below plex Below 10,000)
    Table 4. Key Players of Medium Density Multiplexed Assays (plex Below 500)
    Table 5. Key Players of Low Density Multiplexed Assays (plex Below 5)
    Table 6. Key Players of Next Generation Sequencing Assays
    Table 7. Global Multiplexed Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Multiplexed Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Multiplexed Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Multiplexed Diagnostics Market Share by Region (2017-2022)
    Table 11. Global Multiplexed Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Multiplexed Diagnostics Market Share by Region (2023-2028)
    Table 13. Multiplexed Diagnostics Market Trends
    Table 14. Multiplexed Diagnostics Market Drivers
    Table 15. Multiplexed Diagnostics Market Challenges
    Table 16. Multiplexed Diagnostics Market Restraints
    Table 17. Global Multiplexed Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Multiplexed Diagnostics Market Share by Players (2017-2022)
    Table 19. Global Top Multiplexed Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplexed Diagnostics as of 2021)
    Table 20. Ranking of Global Top Multiplexed Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Multiplexed Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Multiplexed Diagnostics Product Solution and Service
    Table 24. Date of Enter into Multiplexed Diagnostics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Multiplexed Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Multiplexed Diagnostics Revenue Market Share by Type (2017-2022)
    Table 28. Global Multiplexed Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Multiplexed Diagnostics Revenue Market Share by Type (2023-2028)
    Table 30. Global Multiplexed Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Multiplexed Diagnostics Revenue Market Share by Application (2017-2022)
    Table 32. Global Multiplexed Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Multiplexed Diagnostics Revenue Market Share by Application (2023-2028)
    Table 34. North America Multiplexed Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Multiplexed Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Multiplexed Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Multiplexed Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Multiplexed Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Multiplexed Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Multiplexed Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Multiplexed Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Multiplexed Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Multiplexed Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Agilent Technologies Company Detail
    Table 45. Agilent Technologies Business Overview
    Table 46. Agilent Technologies Multiplexed Diagnostics Product
    Table 47. Agilent Technologies Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
    Table 48. Agilent Technologies Recent Development
    Table 49. Bio-Rad Laboratories Company Detail
    Table 50. Bio-Rad Laboratories Business Overview
    Table 51. Bio-Rad Laboratories Multiplexed Diagnostics Product
    Table 52. Bio-Rad Laboratories Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
    Table 53. Bio-Rad Laboratories Recent Development
    Table 54. BioMerieux Company Detail
    Table 55. BioMerieux Business Overview
    Table 56. BioMerieux Multiplexed Diagnostics Product
    Table 57. BioMerieux Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
    Table 58. BioMerieux Recent Development
    Table 59. F. Hoffmann-La Roche Company Detail
    Table 60. F. Hoffmann-La Roche Business Overview
    Table 61. F. Hoffmann-La Roche Multiplexed Diagnostics Product
    Table 62. F. Hoffmann-La Roche Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
    Table 63. F. Hoffmann-La Roche Recent Development
    Table 64. Illumina Company Detail
    Table 65. Illumina Business Overview
    Table 66. Illumina Multiplexed Diagnostics Product
    Table 67. Illumina Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
    Table 68. Illumina Recent Development
    Table 69. Luminex Company Detail
    Table 70. Luminex Business Overview
    Table 71. Luminex Multiplexed Diagnostics Product
    Table 72. Luminex Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
    Table 73. Luminex Recent Development
    Table 74. Hologic Company Detail
    Table 75. Hologic Business Overview
    Table 76. Hologic Multiplexed Diagnostics Product
    Table 77. Hologic Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
    Table 78. Hologic Recent Development
    Table 79. Thermo Fisher Scientific Company Detail
    Table 80. Thermo Fisher Scientific Business Overview
    Table 81. Thermo Fisher Scientific Multiplexed Diagnostics Product
    Table 82. Thermo Fisher Scientific Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
    Table 83. Thermo Fisher Scientific Recent Development
    Table 84. Siemens Healthineers Company Detail
    Table 85. Siemens Healthineers Business Overview
    Table 86. Siemens Healthineers Multiplexed Diagnostics Product
    Table 87. Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
    Table 88. Siemens Healthineers Recent Development
    Table 89. Abbott Laboratories Company Detail
    Table 90. Abbott Laboratories Business Overview
    Table 91. Abbott Laboratories Multiplexed Diagnostics Product
    Table 92. Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
    Table 93. Abbott Laboratories Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Multiplexed Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Very High Density Multiplexed Assays (Above 10,000-plex) Features
    Figure 3. High Density Multiplexed Assays (500 Below plex Below 10,000) Features
    Figure 4. Medium Density Multiplexed Assays (plex Below 500) Features
    Figure 5. Low Density Multiplexed Assays (plex Below 5) Features
    Figure 6. Next Generation Sequencing Assays Features
    Figure 7. Global Multiplexed Diagnostics Market Share by Application in 2021 & 2028
    Figure 8. Academic Research Institutes Case Studies
    Figure 9. Hospital Case Studies
    Figure 10. Pharmaceutical Companies Case Studies
    Figure 11. Clinical Research Organizations Case Studies
    Figure 12. Diagnostic Laboratories Case Studies
    Figure 13. Multiplexed Diagnostics Report Years Considered
    Figure 14. Global Multiplexed Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Multiplexed Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Multiplexed Diagnostics Market Share by Region: 2021 VS 2028
    Figure 17. Global Multiplexed Diagnostics Market Share by Players in 2021
    Figure 18. Global Top Multiplexed Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplexed Diagnostics as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Multiplexed Diagnostics Revenue in 2021
    Figure 20. North America Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Multiplexed Diagnostics Market Share by Country (2017-2028)
    Figure 22. United States Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Multiplexed Diagnostics Market Share by Country (2017-2028)
    Figure 26. Germany Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Multiplexed Diagnostics Market Share by Region (2017-2028)
    Figure 34. China Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Multiplexed Diagnostics Market Share by Country (2017-2028)
    Figure 42. Mexico Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Multiplexed Diagnostics Market Share by Country (2017-2028)
    Figure 46. Turkey Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Multiplexed Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Agilent Technologies Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
    Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
    Figure 50. BioMerieux Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
    Figure 51. F. Hoffmann-La Roche Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
    Figure 52. Illumina Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
    Figure 53. Luminex Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
    Figure 54. Hologic Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
    Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
    Figure 56. Siemens Healthineers Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
    Figure 57. Abbott Laboratories Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Agilent Technologies
Bio-Rad Laboratories
BioMerieux
F. Hoffmann-La Roche
Illumina
Luminex
Hologic
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories
Frequently Asked Questions
Multiplexed Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Multiplexed Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Multiplexed Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Mycotoxin Binders

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More